CJ Cheiljedang

CJ CheilJedang reported second quarter 2026 earnings driven by strong US market growth in GSP categories like mandu and hapan, particularly through Costco channels, while its bio business faces headwinds from intensifying competition in China and price declines in products such as tryptophan. The company expects US tariffs on Chinese lysine to improve market conditions and support amino acid price recovery, with final tariffs implemented in September and benefits more visible in the fourth quarter. Technical solutions, which accounts for about 10% of total sales excluding logistics, is positioned as a long-term growth driver through high-value products like taste and nutrition, PHA, and health and wellness. Net debt increased by KRW800 billion due to FX rate hikes, seasonal working capital needs, and CapEx investments, but is expected to normalize by year-end. The company maintained its 2026 CapEx forecast of KRW1.1 trillion, with 60% to 70% allocated to new projects, primarily the new lifestyle foods business.

CJ BIO will introduce its TasteNrich Taste Lab at IFT FIRST 2026 in Chicago from July 13 to 15. The application-focused tasting experience at Booth #1117 is designed to help food and beverage developers address formulation challenges including sodium reduction, clean label development, fat and dairy reduction, plant protein masking, and savory flavor enhancement. Presented under the concept "From Lab to Applications," the Taste Lab will feature real food and beverage demos such as a reduced-sodium pasta salad, a reduced-fat matcha latte, a dairy-reduced cheese ramen, a pea protein cracker with off-note masking, and a clean-label cheddar jalapeño mayo. CJ BIO's natural taste solution portfolio aims to help brands build more balanced taste systems by optimizing salt perception, umami, mouthfeel, masking, flavor balance, and savory impact. Visitors can schedule meetings with CJ BIO experts to discuss product needs and potential collaborations.